Literature DB >> 1833515

Impairment of helper T-cell function and lymphokine-activated killer cytotoxicity following severe head injury.

K B Quattrocchi1, E H Frank, C H Miller, A Amin, B W Issel, F C Wagner.   

Abstract

Infection is a major complication of severe head injury, occurring in 50% to 75% of patients who survive to hospitalization. Previous investigations of immune activity following head injury have demonstrated suppression of helper T-cell activation. In this study, the in vitro production of interferon-gamma (INF-gamma), interleukin-1 (IL-1), and interleukin-2 (IL-2) was determined in 25 head-injured patients following incubation of peripheral blood lymphocytes (PBL's) with the lymphocyte mitogen phytohemagglutin (PHA). In order to elucidate the functional status of cellular cytotoxicity, lymphokine-activated killer (LAK) cell cytotoxicity assays were performed both prior to and following incubation of PBL's with IL-2 in five patients with severe head injury. The production of INF-gamma and IL-2 by PHA-stimulated PBL's was maximally depressed within 24 hours of injury (p less than 0.001 for INF-gamma, p = 0.035 for IL-2) and partially normalized within 21 days of injury. There was no change in the production of IL-1. When comparing the in vitro LAK cell cytotoxicity of PBL's from head-injured patients and normal subjects, there was a significant depression in LAK cell cytotoxicity both prior to (p = 0.010) and following (p less than 0.001) incubation of PBL's with IL-2. The results of this study indicate that IL-2 and INF-gamma production, normally required for inducing cell-mediated immunity, is suppressed following severe head injury. The failure of IL-2 to enhance LAK cell cytotoxicity suggest that factors other than decreased IL-2 production, such as inhibitory soluble mediators or suppressor lymphocytes, may be responsible for the reduction in cellular immune activity following severe head injury. These findings may have significant implications in designing clinical studies aimed at reducing the incidence of infection following severe head injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833515     DOI: 10.3171/jns.1991.75.5.0766

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege.

Authors:  Jose L Vega; Hiroshi Keino; Sharmila Masli
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

2.  Severe traumatic head injury affects systemic cytokine expression.

Authors:  Damien J LaPar; Laura H Rosenberger; Dustin M Walters; Traci L Hedrick; Brian R Swenson; Jeffrey S Young; Lesly A Dossett; Addison K May; Robert G Sawyer
Journal:  J Am Coll Surg       Date:  2012-02-17       Impact factor: 6.113

3.  Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.

Authors:  Anna Teresa Mazzeo; Gretchen M Brophy; Charlotte B Gilman; Oscar Luís Alves; Jaime R Robles; Ronald L Hayes; John T Povlishock; M Ross Bullock
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

4.  Peri-operative changes of cellular and humoral components of immunity with brain tumour surgery.

Authors:  W A Dauch; D Krex; J Heymanns; B Zeithammer; B L Bauer
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

5.  Leukocytosis after routine cranial surgery: A potential marker for brain damage in intracranial surgery.

Authors:  Deepak Agrawal; Nilesh Kurwale; Bhawani Shankar Sharma
Journal:  Asian J Neurosurg       Date:  2016 Apr-Jun

Review 6.  The Peripheral Immune System and Traumatic Brain Injury: Insight into the role of T-helper cells.

Authors:  Wangxiao Bao; Yajun Lin; Zuobing Chen
Journal:  Int J Med Sci       Date:  2021-09-09       Impact factor: 3.738

Review 7.  Nosocomial infections and immunity: lesson from brain-injured patients.

Authors:  Tomasz Dziedzic; Agnieszka Slowik; Andrzej Szczudlik
Journal:  Crit Care       Date:  2004-02-19       Impact factor: 9.097

Review 8.  Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus.

Authors:  Jon Hazeldine; Janet M Lord; Antonio Belli
Journal:  Front Neurol       Date:  2015-11-05       Impact factor: 4.003

Review 9.  Cellular infiltration in traumatic brain injury.

Authors:  Aftab Alam; Eric P Thelin; Tamara Tajsic; Danyal Z Khan; Abdelhakim Khellaf; Rickie Patani; Adel Helmy
Journal:  J Neuroinflammation       Date:  2020-11-03       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.